Supercharged immune cells show promise against stubborn leukemia
NCT ID NCT02782546
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 23 times
Summary
This study tests whether giving patients special 'memory-like' natural killer (NK) cells after a stem cell transplant can help keep acute myeloid leukemia (AML) away. It includes 60 adults with AML that did not respond to or came back after standard treatments. The goal is to see if this approach improves leukemia-free survival at 100 days compared to expected rates.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.